Go Pro

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Elanco Animal Health Incorporated stock logo
ELAN
Elanco Animal Health
$22.21
+2.0%
$23.81
$19.40
▼
$27.98
$11.10B1.715.67 million shs5.00 million shs
IDEXX Laboratories, Inc. stock logo
IDXX
IDEXX Laboratories
$518.39
+0.1%
$543.61
$500.61
▼
$769.98
$40.84B1.55569,067 shs288,811 shs
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
$1,144.20
-0.5%
$1,176.33
$783.85
▼
$1,292.65
$1.08T0.462.99 million shs2.05 million shs
ProShares Pet Care ETF stock logo
PAWZ
ProShares Pet Care ETF
$46.76
+0.7%
$50.51
$45.96
▼
$57.44
$50.50M1.163,835 shs360 shs
Pfizer Inc. stock logo
PFE
Pfizer
$27.81
-1.1%
$27.41
$23.62
▼
$29.21
$158.50B0.3240.71 million shs34.99 million shs
Zoetis Inc. stock logo
ZTS
Zoetis
$69.62
+0.8%
$74.39
$68.77
▼
$148.79
$28.77B0.755.61 million shs5.26 million shs
 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Elanco Animal Health Incorporated stock logo
ELAN
Elanco Animal Health
-2.98%-2.44%-8.90%-12.66%+4.66%
IDEXX Laboratories, Inc. stock logo
IDXX
IDEXX Laboratories
-0.85%+0.85%-5.03%-7.18%-16.51%
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
-0.93%-2.73%-0.74%-4.75%+39.35%
ProShares Pet Care ETF stock logo
PAWZ
ProShares Pet Care ETF
-1.19%-1.13%-10.42%-5.23%-17.06%
Pfizer Inc. stock logo
PFE
Pfizer
-1.68%-1.08%-1.65%+15.68%+3.28%
Zoetis Inc. stock logo
ZTS
Zoetis
-0.99%-1.74%-10.53%-7.58%-52.97%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Elanco Animal Health Incorporated stock logo
ELAN
Elanco Animal Health
$22.21
+2.0%
$23.81
$19.40
▼
$27.98
$11.10B1.715.67 million shs5.00 million shs
IDEXX Laboratories, Inc. stock logo
IDXX
IDEXX Laboratories
$518.39
+0.1%
$543.61
$500.61
▼
$769.98
$40.84B1.55569,067 shs288,811 shs
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
$1,144.20
-0.5%
$1,176.33
$783.85
▼
$1,292.65
$1.08T0.462.99 million shs2.05 million shs
ProShares Pet Care ETF stock logo
PAWZ
ProShares Pet Care ETF
$46.76
+0.7%
$50.51
$45.96
▼
$57.44
$50.50M1.163,835 shs360 shs
Pfizer Inc. stock logo
PFE
Pfizer
$27.81
-1.1%
$27.41
$23.62
▼
$29.21
$158.50B0.3240.71 million shs34.99 million shs
Zoetis Inc. stock logo
ZTS
Zoetis
$69.62
+0.8%
$74.39
$68.77
▼
$148.79
$28.77B0.755.61 million shs5.26 million shs
 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Elanco Animal Health Incorporated stock logo
ELAN
Elanco Animal Health
-2.98%-2.44%-8.90%-12.66%+4.66%
IDEXX Laboratories, Inc. stock logo
IDXX
IDEXX Laboratories
-0.85%+0.85%-5.03%-7.18%-16.51%
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
-0.93%-2.73%-0.74%-4.75%+39.35%
ProShares Pet Care ETF stock logo
PAWZ
ProShares Pet Care ETF
-1.19%-1.13%-10.42%-5.23%-17.06%
Pfizer Inc. stock logo
PFE
Pfizer
-1.68%-1.08%-1.65%+15.68%+3.28%
Zoetis Inc. stock logo
ZTS
Zoetis
-0.99%-1.74%-10.53%-7.58%-52.97%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Elanco Animal Health Incorporated stock logo
ELAN
Elanco Animal Health
2.75
Moderate Buy$29.7033.71% Upside
IDEXX Laboratories, Inc. stock logo
IDXX
IDEXX Laboratories
2.60
Moderate Buy$747.0044.10% Upside
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
2.87
Moderate Buy$1,311.9614.66% Upside
ProShares Pet Care ETF stock logo
PAWZ
ProShares Pet Care ETF
2.55
Moderate Buy$46.76N/A
Pfizer Inc. stock logo
PFE
Pfizer
2.19
Hold$28.392.09% Upside
Zoetis Inc. stock logo
ZTS
Zoetis
2.32
Hold$101.0845.18% Upside

Current Analyst Ratings Breakdown

Latest ZTS, ELAN, PAWZ, PFE, LLY, and IDXX Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
10/1/2026
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
Reiterated RatingOutperform
9/30/2026
Elanco Animal Health Incorporated stock logo
ELAN
Elanco Animal Health
Reiterated RatingOverweight
9/28/2026
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
Boost Price TargetOverweight$1,400.00 ➝ $1,500.00
9/22/2026
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
Reiterated RatingBuy$1,250.00
9/18/2026
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
Boost Price TargetBuy$1,273.00 ➝ $1,284.00
9/17/2026
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
Boost Price TargetBuy$1,367.00 ➝ $1,371.00
9/15/2026
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
Set Price TargetHold ➝ Buy$1,400.00
9/15/2026
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
UpgradeHold ➝ Buy$1,400.00
9/10/2026
Pfizer Inc. stock logo
PFE
Pfizer
Boost Price TargetHold$28.00 ➝ $30.00
9/10/2026
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
Boost Price TargetReduce$850.00 ➝ $940.00
9/9/2026
Zoetis Inc. stock logo
ZTS
Zoetis
Reiterated RatingSell (D)
(Data available from 10/2/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Elanco Animal Health Incorporated stock logo
ELAN
Elanco Animal Health
$4.72B2.35$2.30 per share9.65$13.18 per share1.69
IDEXX Laboratories, Inc. stock logo
IDXX
IDEXX Laboratories
$4.30B9.49$14.98 per share34.61$20.10 per share25.79
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
$65.18B16.53$24.86 per share46.03$28.07 per share40.76
ProShares Pet Care ETF stock logo
PAWZ
ProShares Pet Care ETF
N/AN/AN/AN/AN/AN/A
Pfizer Inc. stock logo
PFE
Pfizer
$62.58B2.53$4.28 per share6.49$15.26 per share1.82
Zoetis Inc. stock logo
ZTS
Zoetis
$9.47B3.04$7.54 per share9.23$7.56 per share9.21
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Elanco Animal Health Incorporated stock logo
ELAN
Elanco Animal Health
-$232M-$0.41N/A17.221.60-3.96%8.13%3.99%11/6/2026 (Estimated)
IDEXX Laboratories, Inc. stock logo
IDXX
IDEXX Laboratories
$1.06B$14.2236.4631.192.7925.03%71.96%33.60%11/2/2026 (Estimated)
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
$20.64B$29.8038.4024.531.4233.53%97.83%23.23%10/29/2026 (Estimated)
ProShares Pet Care ETF stock logo
PAWZ
ProShares Pet Care ETF
N/AN/A23.65N/AN/AN/AN/AN/AN/A
Pfizer Inc. stock logo
PFE
Pfizer
$7.77B$0.7636.599.431.926.80%19.63%8.46%11/3/2026 (Estimated)
Zoetis Inc. stock logo
ZTS
Zoetis
$2.67B$6.0711.4711.001.6327.49%74.89%18.59%11/5/2026 (Estimated)

Latest ZTS, ELAN, PAWZ, PFE, LLY, and IDXX Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
10/29/2026Q3 2026
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
$9.92N/AN/AN/A$22.32 billionN/A
8/6/2026Q2 2026
Zoetis Inc. stock logo
ZTS
Zoetis
$1.85$1.87+$0.02$1.65$2.50 billion$2.47 billion
8/5/2026Q2 2026
Elanco Animal Health Incorporated stock logo
ELAN
Elanco Animal Health
$0.2692$0.34+$0.0708$0.11$1.31 billion$1.37 billion
8/5/2026Q2 2026
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
$6.40$8.38+$1.98$7.94$20.82 billion$22.97 billion
8/4/2026Q2 2026
IDEXX Laboratories, Inc. stock logo
IDXX
IDEXX Laboratories
$3.94$4.27+$0.33$4.27$1.20 billion$1.22 billion
8/4/2026Q2 2026
Pfizer Inc. stock logo
PFE
Pfizer
$0.6820$0.77+$0.0880-$0.04$14.40 billion$15.03 billion
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Elanco Animal Health Incorporated stock logo
ELAN
Elanco Animal Health
N/AN/AN/AN/AN/A
IDEXX Laboratories, Inc. stock logo
IDXX
IDEXX Laboratories
N/AN/AN/AN/AN/A
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
$6.920.60%+15.18%23.22%11 Years
ProShares Pet Care ETF stock logo
PAWZ
ProShares Pet Care ETF
$0.420.90%N/AN/AN/A
Pfizer Inc. stock logo
PFE
Pfizer
$1.726.19%-13.20%226.32%16 Years
Zoetis Inc. stock logo
ZTS
Zoetis
$2.123.06%+20.11%34.93%14 Years
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Elanco Animal Health Incorporated stock logo
ELAN
Elanco Animal Health
0.58
2.05
1.10
IDEXX Laboratories, Inc. stock logo
IDXX
IDEXX Laboratories
0.19
1.17
0.87
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
1.41
1.35
1.00
ProShares Pet Care ETF stock logo
PAWZ
ProShares Pet Care ETF
N/AN/AN/A
Pfizer Inc. stock logo
PFE
Pfizer
0.71
1.27
0.96
Zoetis Inc. stock logo
ZTS
Zoetis
2.87
3.08
1.84

Institutional Ownership

CompanyInstitutional Ownership
Elanco Animal Health Incorporated stock logo
ELAN
Elanco Animal Health
97.48%
IDEXX Laboratories, Inc. stock logo
IDXX
IDEXX Laboratories
87.84%
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
82.53%
ProShares Pet Care ETF stock logo
PAWZ
ProShares Pet Care ETF
N/A
Pfizer Inc. stock logo
PFE
Pfizer
68.36%
Zoetis Inc. stock logo
ZTS
Zoetis
92.80%
CompanyEmployeesShares OutstandingFree FloatOptionable
Elanco Animal Health Incorporated stock logo
ELAN
Elanco Animal Health
9,400499.62 million493.93 millionOptionable
IDEXX Laboratories, Inc. stock logo
IDXX
IDEXX Laboratories
11,00078.78 million78.16 millionOptionable
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
50,000941.36 million940.04 millionOptionable
ProShares Pet Care ETF stock logo
PAWZ
ProShares Pet Care ETF
N/A1.08 millionN/ANot Optionable
Pfizer Inc. stock logo
PFE
Pfizer
75,0005.70 billion5.66 billionOptionable
Zoetis Inc. stock logo
ZTS
Zoetis
14,500413.22 million412.32 millionOptionable

Recent News About These Companies

Zoetis (ZTS) Stock Sinks As Market Gains: Here's Why
Zoetis (ZTS) Stock Sinks As Market Gains: Here's Why
Zoetis Inc. (NYSE:ZTS) Stock Has Consensus Target Price of $101.08
Zoetis (NYSE:ZTS) Hits New 1-Year Low - What's Next?
Zoetis: Priced For The Worst, Worth Buying
Zoetis Inc. $ZTS Stock Sold by QRG Capital Management Inc.
Nykredit A S Buys New Position in Zoetis Inc. $ZTS
Zoetis: The Worst May Be Priced In

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Elanco Animal Health stock logo

Elanco Animal Health NYSE:ELAN

$22.21 +0.44 (+2.03%)
Closing price 03:59 PM Eastern
Extended Trading
$22.14 -0.08 (-0.35%)
As of 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet health therapeutics for pain, osteoarthritis, ear infections, cardiovascular, and dermatology indications in canines and felines under the Galliprant and Claro brands; vaccines, antibiotics, parasiticides, and other products for use in poultry and aquaculture production, as well as nutritional health products, including enzymes, probiotics, and prebiotics; and a range of vaccines, antibiotics, implants, parasiticides, and other products used in ruminant and swine production under the Rumensin and Baytril brands. The company sells its products to third-party distributors; veterinarians; and farm animal producers, including beef and dairy farmers, as well as pork, poultry, and aquaculture operations. Elanco Animal Health Incorporated was founded in 1954 and is headquartered in Greenfield, Indiana.

IDEXX Laboratories stock logo

IDEXX Laboratories NASDAQ:IDXX

$518.39 +0.64 (+0.12%)
Closing price 04:00 PM Eastern
Extended Trading
$518.47 +0.08 (+0.02%)
As of 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

IDEXX Laboratories, Inc. develops, manufactures, and distributes products primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets in Africa, the Asia Pacific, Canada, Europe, Latin America, and internationally. The company operates through three segments: Companion Animal Group; Water Quality Products; and Livestock, Poultry and Dairy. It also provides point-of-care veterinary diagnostic products, including instruments, consumables, and rapid assay test kits; veterinary reference laboratory diagnostic and consulting services; practice management and diagnostic imaging systems and services for veterinarians; and health monitoring, biological materials testing, and laboratory diagnostic instruments, and services for biomedical research community. In addition, the company offers diagnostic and health-monitoring products for livestock, poultry, and dairy; products that test water for various microbiological contaminants; point-of-care electrolytes and blood gas analyzers; in-clinic chemistry, blood and urine chemistry, hematology, immunoassay, urinalysis, and coagulation analyzers; and SNAP rapid assays test kits. Further, it provides Colilert, Colilert-18, and Colisure tests, which detect the presence of total coliforms and E. coli in water; Enterolert, Pseudalert, Filta-Max and Filta-Max xpress, Legiolert, and Quanti-Tray products; and veterinary software and services for independent veterinary clinics and corporate groups. Additionally, the company offers human medical point-of-care products and laboratory diagnostics services. The company markets its products through marketing, customer service, sales, and technical service groups, as well as through independent distributors and other resellers. IDEXX Laboratories, Inc. was incorporated in 1983 and is headquartered in Westbrook, Maine.

Eli Lilly and Company stock logo

Eli Lilly and Company NYSE:LLY

$1,144.20 -5.65 (-0.49%)
Closing price 03:59 PM Eastern
Extended Trading
$1,143.50 -0.70 (-0.06%)
As of 07:35 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. The company offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; Jardiance, Mounjaro, and Trulicity for type 2 diabetes; and Zepbound for obesity. It also provides oncology products, including Alimta, Cyramza, Erbitux, Jaypirca, Retevmo, Tyvyt, and Verzenio. In addition, the company offers Olumiant for rheumatoid arthritis, atopic dermatitis, severe alopecia areata, and COVID-19; Taltz for plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, and non-radiographic axial spondylarthritis; Omvoh for ulcerative colitis; Cymbalta for depressive disorder, diabetic peripheral neuropathic pain, generalized anxiety disorder, fibromyalgia, and chronic musculoskeletal pain; Ebglyss for severe atopic dermatitis; and Emgality for migraine prevention and episodic cluster headache. Further, it provides Cialis for erectile dysfunction and benign prostatic hyperplasia; and Forteo for osteoporosis. It has collaborations with Incyte Corporation; Boehringer Ingelheim Pharmaceuticals, Inc.; F. Hoffmann-La Roche Ltd and Genentech, Inc.; Biologics, Inc., AbCellera Biologics Inc.; and Chugai Pharmaceutical Co., Ltd. The company was founded in 1876 and is headquartered in Indianapolis, Indiana.

ProShares Pet Care ETF stock logo

ProShares Pet Care ETF BATS:PAWZ

$46.76 +0.33 (+0.71%)
Closing price 04:10 PM Eastern
Extended Trading
$46.78 +0.02 (+0.04%)
As of 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

The ProShares Pet Care ETF (PAWZ) is an exchange-traded fund that is based on the FactSet Pet Care index. The fund tracks a tier-weighted index of global equities related to pet ownership. PAWZ was launched on Nov 5, 2018 and is managed by ProShares.

Pfizer stock logo

Pfizer NYSE:PFE

$27.81 -0.31 (-1.11%)
Closing price 03:59 PM Eastern
Extended Trading
$27.80 -0.01 (-0.05%)
As of 07:35 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States, Europe, and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic, migraine, and women's health under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral products under the Comirnaty and Paxlovid brands. It also provides medicines and vaccines in various therapeutic areas, such as biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Litfulo, Velsipity, and Cibinqo brands; amyloidosis, hemophilia, endocrine diseases, and sickle cell disease under the Vyndaqel family, Oxbryta, BeneFIX, Somavert, Ngenla, and Genotropin brands; sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Zavicefta, Zithromax, and Panzyga brands; and biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Inlyta, Bosulif, Mektovi, Padcev, Adcetris, Talzenna, Tukysa, Elrexfio, Tivdak, Lorbrena, and Braftovi brands. In addition, the company involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, retail pharmacies, and integrated delivery systems. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Merck KGaA; and BioNTech SE. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Zoetis stock logo

Zoetis NYSE:ZTS

$69.62 +0.52 (+0.76%)
Closing price 03:59 PM Eastern
Extended Trading
$69.56 -0.07 (-0.10%)
As of 07:31 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses. It also offers parasiticides, vaccines, dermatology, other pharmaceutical, anti-infectives, animal health diagnostics, and medicated feed additives. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, which include nutritionals, as well as products and services in biodevices, genetic tests, and precision animal health. It markets its products to veterinarians, livestock producers, and pet owners. The company has collaboration Blacksmith Medicines, Inc. to discover and develop novel antibiotics for animal health. Zoetis Inc. was founded in 1952 and is headquartered in Parsippany, New Jersey.